Skip to content

Insider · CIK 0002001162

Brent Pfeiffenberger

ceopresidentofficerdirector

Files at IPSC (Century Therapeutics, Inc.). First filing Feb 20, 2025, latest Jun 11, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $45k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

IPSC: Century Therapeutics, Inc.

IPSCOct 9, 2026 · close 1.47

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
40Moderate
IPSCsell 4
Century Therapeutics, Inc.
$295
475 shares
-0%+61% from low-64% from high
40Moderate
IPSCsell 3
Century Therapeutics, Inc.
$16k
29,552 shares
-2%+44% from low-67% from high
40Moderate
IPSCsell 4
Century Therapeutics, Inc.
$1,375
2,235 shares
-0%-
30Weak
IPSCsell
Century Therapeutics, Inc.
$27k
34,712 shares
-3%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 11, 2026IPSC
Century Therapeutics, Inc.
FTax withholding
Common Stock
-13,850$1.94$27k3,633,83927 d ago
Sep 4, 2026IPSC
Century Therapeutics, Inc.
FTax withholding
Common Stock
-463$2.11$9773,633,83933 d ago
Jun 9, 2025IPSC
Century Therapeutics, Inc.
SOpen-market sale
Common Stock
-475$0.62$2951,681,783Jun 11, 2025
May 16, 2025IPSC
Century Therapeutics, Inc.
SOpen-market sale
Common Stock
-29,552$0.55$16k1,682,258May 20, 2025
Mar 10, 2025IPSC
Century Therapeutics, Inc.
SOpen-market sale
Common Stock
-2,235$0.62$1,3751,190,310Mar 12, 2025
Mar 11, 2025IPSC
Century Therapeutics, Inc.
AGrant or award
Common Stock
+521,500$0.00$01,711,810Mar 12, 2025
Mar 11, 2025IPSC
Century Therapeutics, Inc.
AGrant or award
Stock Option (right to buy)derivative
+521,500$0.00$0521,500Mar 12, 2025
Feb 18, 2025IPSC
Century Therapeutics, Inc.
SOpen-market sale
Common Stock
-34,712$0.78$27k1,192,545Feb 20, 2025
Dec 4, 2024IPSC
Century Therapeutics, Inc.
FTax withholding
Common Stock
-243,447$1.44$351k1,227,257Dec 6, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Brent Pfeiffenberger: insider trades and track record | InsiderTell